APA (7th ed.) Citation

Zhang, Z., Xue, J., Yang, Y., Fang, W., Huang, Y., Zhao, S., . . . Zhao, H. (2024). Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors. Wiley. https://doi.org/10.1002/mco2.586

Chicago Style (17th ed.) Citation

Zhang, Zhonghan, et al. Influence of TP53 Mutation on Efficacy and Survival in Advanced EGFR‐mutant Non‐small Cell Lung Cancer Patients Treated with Third‐generation EGFR Tyrosine Kinase Inhibitors. Wiley, 2024. https://doi.org/10.1002/mco2.586.

MLA (9th ed.) Citation

Zhang, Zhonghan, et al. Influence of TP53 Mutation on Efficacy and Survival in Advanced EGFR‐mutant Non‐small Cell Lung Cancer Patients Treated with Third‐generation EGFR Tyrosine Kinase Inhibitors. Wiley, 2024. https://doi.org/10.1002/mco2.586.